CLINICAL_TRIALS ClinicalTrials.gov record update

A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies Using Melphalan for T-Cell Tolerization

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01350258
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:44.499211+00:00
Published At: 2014-10-24T00:00:00+00:00
Record Updated At: 2025-05-31
Results Posted At: 2014-10-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hematologic Malignancies", "Acute Leukemia", "Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes", "Hodgkin\u0027s Lymphoma", "Non-Hodgkin\u0027s Lymphoma", "Myeloma", "Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-31"
protocolSection.identificationModule.nctId: "NCT01350258"
protocolSection.identificationModule.officialTitle: "A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies Using Melphalan for T-Cell Tolerization"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-10-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.